
Synthesis of novel (+)-sclareolide-based homodrimane sesquiterpenoids bearing hydrazinecarbothioamide or N-substituted 1,2,4-triazole unit has been reported. These heterocyclic compounds demonstrate promising in vitro antifungal and antibacterial activities toward fungal species Aspergillus niger, Fusarium solani, Penicillium chrysogenum, Penicillium frequentans, and Alternaria alternata and bacteria strains Bacillus sp. and Pseudomonas aeruginosa at minimum inhibitory concentration level of μg/ml. In addition, two homodrimane sesquiterpenoids with hydrazinecarbothioamide fragment show cytotoxicity toward human ovarian carcinoma cells A2780 and A2780cis with half maximal inhibitory concentration values in range of 9–15 μM.
This is a preview of subscription content, access via your institution.




References
Jansen, B. J. M.; de Groot, Ae. Nat. Prod. Rep. 2004, 21, 449.
(a) Kubo, I. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, 1995, Vol. 17, p. 233. (b) Taniguchi, M.; Yano, Y.; Motoba, K.; Tanaka, T.; Oi, S.; Haraguchi, H.; Hashimoto, K.; Kubo, I. Agric. Biol. Chem. 1988, 52, 1881.
Fritz, G. L.; Mills, G. D., Jr.; Warthen, J. D., Jr.; Waters, R. M. J. Chem. Ecol. 1989, 15, 2607.
Barrero, A. F.; Manzaneda, E. A.; Altarejos, J.; Salido, S.; Ramos, J. M.; Simmonds, M. S. J.; Blaney, W. M. Tetrahedron 1995, 51, 7435.
Ciocarlan, A.; Aricu, A.; Lungu, L.; Edu, C.; Barba, A.; Shova, S.; Mangalagiu, I. I.; D'Ambrosio, M.; Nicolescu, A.; Deleanu, C.; Vornicu, N. Synlett 2017, 565.
Viegas, C., Jr.; Danuello, A.; da Silva Bolzani, V.; Barreiro, E. J.; Fraga, C. A. M. Curr. Med. Chem. 2007, 14, 1829.
Kuchkova, K.; Aricu, A.; Barba, A.; Vlad, P.; Shova, S.; Secara, E.; Ungur, N.; Zbancioc, Gh.; Mangalagiu, I. I. Synlett 2013, 697.
Kuchkova, K.; Aricu, A.; Secara, E.; Barba, A.; Vlad, P.; Ungur, N.; Tuchilus, C.; Shova, S.; Zbancioc, Gh.; Mangalagiu, I. I. Med. Chem. Res. 2014, 23, 1559.
(a) Kharb, R.; Sharma, P. C.; Yar, M. S. J. Enzyme Inhib. Med. Chem. 2011, 26, 1. (b) Gupta, D.; Jain, D. K. J. Adv. Pharm. Technol. Res. 2015, 6, 141. (c) Shen, Q.-K.; Liu, C.-F.; Zhang, H.-J.; Tian, Y.-S.; Quan, Z.-S. Bioorg. Med. Chem. Lett. 2017, 27, 4871. (d) Silva-Ortiz, A. V.; Bratoeff, E.; Ramírez-Apan, T.; Heuze, Y.; Sánchez, A.; Soriano, J.; Cabeza, M. Bioorg. Med. Chem. 2015, 23, 7535.
Kuchkova, K. I.; Aricu, A. N.; Sekara, E. S.; Barba, A. N.; Vlad, P. F.; Makaev, F. Z.; Melnic, E.; Kravtsov, V. Kh. Chem. Nat. Compd. 2015, 51, 684. [Khim. Prir. Soedin. 2015, 589.]
Cucicova, C.; Rudic, V.; Aricu, A.; Cepoi, L.; Rudi, L.; Secara, E.; Valuta, A.; Barba, A.; Miscu, V.; Vlad, P.; Chiriac, T. MD Patent 4327.
Styngach, E. P.; Malinovskii, S. T.; Bets, L. P.; Vlad, L. A.; Gdanets, M.; Makaev, F. Z. J. Struct. Chem. 2005, 46, 765. [Zh. Struktur. Khim. 2005, 46, 785.]
Namratha, B.; Gaonkar, S. L. Int. J. Pharm. Pharm. Sci. 2014, 6, 73.
Macaev, F.; Rusu, G.; Pogrebnoi, S.; Gudima, A.; Stingaci, E.; Vlad, L.; Shvets, N.; Kandemirli, F.; Dimoglo, A.; Reynolds, R. Bioorg. Med. Chem. 2005, 13, 4842.
Jogdand, G. F. Ph. D. Thesis, University of Pune: Pune, 2016.
(a) Antimicrobial Susceptibility Testing (AST) Standards M07 and M100; National Committee on Clinical Laboratory Standards (NCCLS), 2003. (b) Cavalieri, S. J.; Harbeck, R. J.; McCarter, Y. S.; Ortez, J. H.; Rankin, I. D.; Sautter, R. L.; Sharp, S. E.; Spiegel, C. A. Manual of Antimicrobial Susceptibility Testing; Coyle, M. B., Ed.; American Society for Microbiology: Washington, 2005. (c) Arendrup, M. C.; Verweij, P.; Nielsen, H. V. Antimicrob. Agents Chemother. 2017, 61, e01659-16. (d) Thompson, G. R., III; Fothergill, A. W.; Wiederhold, N. P.; Vallor, A. C.; Wickes, B. L.; Patterson, T. F. Antimicrob. Agents Chemother. 2008, 52, 2959. (e) Espinel-Ingroff, A.; Rezusta, A. J. Clin. Microbiol. 2002, 40, 2101.
CrysAlis RED, v1.171.34.76; Oxford Diffraction Ltd.: Abingdon, 2003.
Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. Crystallogr. 2009, 42, 339.
Sheldrick, G. M. Acta Crystallogr., Sect. A: Found. Crystallogr. 2008, A64, 112.
Sîrbu, A.; Palamarciuc, O.; Babak, M. V.; Lim, J. M.; Ohui, K.; Enyedy, E. A.; Shova, S.; Darvasiová, D.; Rapta, P.; Ang, W. H.; Arion, V. B. Dalton Trans. 2017, 46, 3833.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary information file containing 1H and 13C NMR spectra of compounds 6, 7a–d, 8a–d, and 9a–d, HRMS of compounds 7c and 8d, and single crystal X-ray crystallographic data of compounds 8c and 9d is available at the journal website http://link.springer.com/journal/10593.
Published in Khimiya Geterotsiklicheskikh Soedinenii, 2019, 55(8), 716–724
Electronic supplementary material
ESM 1
(PDF 7144 kb)
Rights and permissions
About this article
Cite this article
Lungu, L., Ciocarlan, A., Barba, A. et al. Synthesis and Evaluation of Biological Activity of Homodrimane Sesquiterpenoids Bearing Hydrazinecarbothioamide or 1,2,4-Triazole Unit. Chem Heterocycl Comp 55, 716–724 (2019). https://doi.org/10.1007/s10593-019-02526-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-019-02526-1
Keywords
- homodrimane sesquiterpenoid
- hydrazinecarbothioamide
- 1,2,4-triazole
- antibacterial activity
- anticancer activity
- antifungal activity
- microwave irradiation